👏👏👏Congratulations to our brilliant Leukemia Chief Fellow Dr .@r_sazevedo on being awarded 🥇 Best Overall Fellow of The Year Award at our Leukemia graduation! Very many Congratulations to each & all of our graduating fellows 👏!!!! @TapKadia@garciamanero 🙌
Whole genome sequencing revealed clinically relevant alterations missed by standard testing in MDS, identifying 21 novel high-confidence variants in 39% of cases, including key structural and prognostic drivers. Presented at #ASCO26 by Dr. Alex Bataller. @AlexBataller@garciamanero#EndCancer 9/12
🔑 KEY FINDING: 52% of patients showed immunophenotypic shifts after revumenib — often myeloid/stem-like → monocytic/myelomonocytic. Among MRD patients in remission, 67% had antigen expression changes vs. pre-treatment AML! 👇
@AlexBataller
New in @LeukemiaJnl : Outcomes in intensively treated KMT2Ar #AML have improved over time. But low-intensity therapies still show poor results — highlighting the urgent need to explore menin inhibitors
nature.com/articles/s41375-0…#leusm
It is with deep sorrow that we bid our brother @AlmanzaLeukMD farewell today. A brilliant leukemia physician @MDAndersonNews whose light shone so bright; the world is so much darker now.
Please donate to help his family, whom he supported, with costs: gofund.me/f8e20f32